Clinical trial
Benefit of a Subacromial Injection Combining Corticosteroid and Hyaluronic Acid Versus Corticosteroid Alone in Supraspinatus Tendinopathy
NCT06376981 is registered in ClinicalTrials.gov with Centre Hospitalier Departemental Vendee as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Benefit of a Subacromial Injection Combining Corticosteroid and Hyaluronic Acid Versus Corticosteroid Alone in Supraspinatus Tendinopathy
- Lead sponsor
- Centre Hospitalier Departemental Vendee
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- September 19, 2024
- Completion date
- March 19, 2030
- Enrollment
- 132 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
shoulder tendinitis